Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2005
04/14/2005US20050080035 Use of BVDU for inhibiting the growth of hyperproliferative cells
04/14/2005US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases
04/14/2005US20050080002 Methods for the treatment and prevention of cancer
04/14/2005US20050079998 Anti-lipemic drug cromprising effector of sterol regulatory element binding protein-1 (SREBP-1) and serum cholesterol inhibitor, sphingolipid
04/14/2005US20050079995 For treatment of cancers through activation of silenced tumor suppressor genes, promotion of apoptosis in cancerous cells, and inhibition of transcriptional repressor activity in oncogenes; drug screening
04/14/2005US20050079635 Encoded carrier
04/14/2005US20050079629 Lateral flow assay devices and methods of use
04/14/2005US20050079624 Amino acid peptide with high sensitivity labels with carbamate
04/14/2005US20050079623 Method of using a reference control composition for measurement of nucleated red blood cells
04/14/2005US20050079606 Pluripotent stem cells originating in skeletal muscle intestinal tissue
04/14/2005US20050079601 Apparatus comprising rotatable mirrors and ultraviolet emission source for use as tool in DNA and genomic analysis
04/14/2005US20050079600 Bioferrograph for identifying magnetically susceptible particles
04/14/2005US20050079592 Device and method for manufacturing bead array, and method for detecting target substance
04/14/2005US20050079583 Mammalian Zcytor 11
04/14/2005US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics
04/14/2005US20050079568 Measuring protein kinase or phosphatase activity in a sample with a reporter peptide, or a fluorescently-labeled phosphorylatable reporter peptide, cleaved by a protease, without using antibodies or radioactive labels, bioassay
04/14/2005US20050079566 Analytical methods for determination of proteolytic cleavage at specific sites
04/14/2005US20050079565 Detecting and profiling molecular complexes
04/14/2005US20050079564 Test agents for evaluating pharmacological effect of drug and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or prodrugs thereof
04/14/2005US20050079563 Extraction and quanification of vitamins a & d in fluid samples
04/14/2005US20050079562 Using presence of membrane protein (caveolin) in high density lipoprotein fraction of as diagnostic tool in differentiating between benign prostatic hyperplasia and proatate cancer
04/14/2005US20050079561 Detecting cancerous and precancerous cells; obtain tissue sample, incubate with tetrakis dyes, rinse and remove unbound dye, detect fluorescence, fuorescence indicates cancerous or precancerous cells
04/14/2005US20050079560 Detection and treatment of cancers of the colon
04/14/2005US20050079559 Antibodies specific for phosphorylation sites and screening methods using the same antibodies
04/14/2005US20050079558 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
04/14/2005US20050079557 Using presence of prostate specific antigen in blood and or bone marrow tissues a s tool in detection of non-hematopoietic neoplastic tumor cells; immunodiagnostics
04/14/2005US20050079556 Methods of detecting specific cell lysis
04/14/2005US20050079555 Using cytokine specific antibody as diagnostic tool in identifying subsets of activated immune cells
04/14/2005US20050079554 Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications
04/14/2005US20050079552 Spheres comprising immobilized monomolecular layers of amphiphilic molecules via covalent bonds for use as interacting surfaces during biochemical and immunological analysis
04/14/2005US20050079551 organic layer formed on a board and having a surface state in which small sections having a different adsorption property from that of a periphery due to a partial difference in molecular structure; and a particle layer having at least one or more nanoparticles arranged on each of the small sections
04/14/2005US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors
04/14/2005US20050079549 Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same
04/14/2005US20050079548 Preparing compounds which modulate phosphodiesterase activity via crystallographic analysis of active site; peptide mimetics; rational drug design
04/14/2005US20050079547 Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
04/14/2005US20050079545 Method for producing microparticles loaded with proteins
04/14/2005US20050079544 Automated method of metabolic stability analysis of library of compounds by isotope dilution mass spectrometry
04/14/2005US20050079543 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes
04/14/2005US20050079542 Wound monitoring
04/14/2005US20050079541 Immunoadhesin comprising a glycorprotein v1 domain
04/14/2005US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents
04/14/2005US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders
04/14/2005US20050079532 Methods and systems for identifying predisposition to the placebo effect
04/14/2005US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
04/14/2005US20050079528 Method of immobilizing molecules onto a solid phase substrate and method of fabricating a biosensor using the method
04/14/2005US20050079526 Methods and apparatuses for characterizing refolding and aggregation of biological molecules
04/14/2005US20050079524 Manipulating, storing, modeling, visualizing and quantifying datasets for use in determining a genetic pathway in a population; genomics
04/14/2005US20050079515 Compositions, splice variants and methods relating to breast specific nucleic acids and proteins
04/14/2005US20050079513 Classification of patients having diffuse large B-cell lymphoma based upon gene expression
04/14/2005US20050079508 Constraints-based analysis of gene expression data
04/14/2005US20050079507 Target evaluation using biological membrane arrays
04/14/2005US20050079506 support having disposed thereon at least one layer comprising filler and gelatin and a functional compound comprising a first functional group capable of interacting with gelatin and a second functional group capable of interacting with a biological capture agent
04/14/2005US20050079501 Using solid support comprising immobilized G-protein coding sequences as tool in detection and diagnosis of cell proliferative disorders
04/14/2005US20050079500 Using microarray stratification and spectrum analysis to identify, quantify and/or characterizing proteins in mixture
04/14/2005US20050079496 Using nuclear factor of activated t-cells (nf-at) transcription factor expression as diagnostic tool detection and treatment of cell proliferative disorders
04/14/2005US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders
04/14/2005US20050079486 Using liquid crystals to detect affinity microcontact printed biomolecules
04/14/2005US20050079485 Method to detect antibodies specific for type-2 turkey astrovirus
04/14/2005US20050079484 Using preferential biopolymer probes to detect biowarfare agents in drinking water
04/14/2005US20050079483 Novel method of diagnosing, monitoring, and staging prostate cancer
04/14/2005US20050079482 Using hierarchical computational frameworks to identify genes associated with preferential biochemical pathways; computer analysis and gene expression analysis
04/14/2005US20050079474 Emotional state modification method and system
04/14/2005US20050079208 Methods of modulating antigen-specific T cell activity
04/14/2005US20050079186 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals
04/14/2005US20050079184 Antiinflammatory agents; anticancer agents; neurodegenerative disease; autoimmune diseases ; skin disorders; antiarthritic agents; Alzheimer's disease; antidiabetic agents
04/14/2005US20050079180 Manipulatin of oocyte maturation and male germ cell survival
04/14/2005US20050079174 Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis
04/14/2005US20050079170 Expression vectors coding antigen binding structure; mixture of protein monomers
04/14/2005US20050079169 Anti-FcRn antibodies for treatment of auto/allo immune conditions
04/14/2005US20050079134 Calibration skin transfer efficiency ; using computer
04/14/2005US20050079099 Testing sample using computers; measurement; calibration disease
04/14/2005US20050078179 Modulate aptamer and method for detecting target protein by using the same
04/14/2005US20050078004 System to monitor, detect and analyze chemical, radiation and/or biological threats
04/14/2005US20050077901 System for monitoring salinity in a water well
04/14/2005US20050077192 Electrode for active oxygen species and sensor using the electrode
04/14/2005US20050077178 Method and sensor element for determining a gas in a gas mixture
04/14/2005US20050076655 Apparatus and method for controlling a fan, cooling unit and a fresh air damper of an air conditioner through use of a Capno-Switch
04/14/2005DE4433261B4 Neues Verfahren zur funktionellen Charakterisierung von Ionenkanälen sowie der funktionellen Identifizierung von Modulatoren solcher Membranproteine New method for the functional characterization of ion channels and functional identification of modulators of such membrane proteins
04/14/2005DE20023601U1 Meßvorrichtung zum Messen des Zustandes eines Meßgutes bestehend aus Ölen oder Fetten Measuring device for measuring the state of a process medium consisting of oils or fats
04/14/2005DE19918442B4 Färbeautomat zum Einfärben von Objekten zur mikroskopischen Untersuchung Stainer for coloring objects for microscopic examination
04/14/2005DE19724888B4 Gasmeßkopf mit einem elektrochemischen Gassensor Gasmeßkopf with an electrochemical gas sensor
04/14/2005DE10344545A1 New isolated, truncated capsid protein C1 of beak and feather disease virus, useful in vaccines and as a diagnostic agent, and its encoding nucleic acid
04/14/2005DE10344262A1 Steckmodul für einen Flüssigkeits- oder Gassensor Plug-in module for a liquid or gas sensor
04/14/2005DE10343815A1 Diagnosis, particularly of cancer and sepsis, by determining abnormal contents of apolipoprotein C-I in serum or plasma, also therapeutic use of apolipoprotein C-I
04/14/2005DE10343522A1 Verfahren zur Steuerung der Behandlung eines Kristalls mit einer Flüssigkeit A method of controlling the treatment of a crystal with a liquid
04/14/2005DE10343442A1 Quantitative detection of biological contaminants in complex cell mixtures, useful for testing cultures in food processing, by flow cytometry, using fluorescent antibody and magnetic particles
04/14/2005DE10341662A1 Preparation of immunoassay device, useful for detecting antigens, particularly pregnancy hormones, includes incorporation of concurrent antibody to ensure selectivity for a single antigen
04/14/2005DE10341304A1 Measuring state of health of body and organs, freshness of food or criminal expertise, determines and analyses dielectric constant of biological material
04/14/2005DE10341093A1 Probenmodul mit Reservebatterie Sampling module with battery backup
04/14/2005DE102004033137A1 Verfahren und Vorrichtung zur Quantifizierung eines schnellen immunochromatographischen Tests Method and device for quantifying a rapid immunochromatographic test
04/14/2005CA2840691A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
04/14/2005CA2552272A1 An improved apparatus and method for trace sulfur detection using uv fluorescence
04/14/2005CA2545639A1 Regulation of matrix metalloproteinases by psp94 family members
04/14/2005CA2545248A1 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
04/14/2005CA2542021A1 Dmbt1 as a clinical marker and uses thereof
04/14/2005CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis
04/14/2005CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides
04/14/2005CA2541059A1 Fluorescent probes for use in protein kinase inhibitor binding assay
04/14/2005CA2541018A1 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis
04/14/2005CA2541015A1 Igf binding proteins